Clinical Trial: Efficacy of Asciminib in Real-world in Patients With Chronic Myeloid Leukemia in Second or Subsequent Lines

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07640750) titled 'Efficacy of Asciminib in Real-world in Patients With Chronic Myeloid Leukemia in Second or Subsequent Lines' on June 01.

Brief Summary: The goal of this observational study is to evaluate the efficacy and tolerability of asciminib in real-life in patients with chronic myeloid leukemia treated in second or subsequent lines. The main object of the study is to assess the achievement of Major Molecular Response.

Study Start Date: Sept. 01, 2026

Study Type: OBSERVATIONAL

Condition: Chronic Myeloid Leukemia Chronic Myeloid Leukemia - Chronic Phase

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Gruppo Italiano Malattie EMatologiche ...